Skip to main content
Erschienen in: Journal of Natural Medicines 4/2009

01.10.2009 | Original Paper

Ameliorative effects of Vaccaria segetalis extract on osteopenia in ovariectomized rats

verfasst von: Chun-Ching Shih, Cheng-Hsiu Lin, Wei-Li Lin

Erschienen in: Journal of Natural Medicines | Ausgabe 4/2009

Einloggen, um Zugang zu erhalten

Abstract

The purpose of this study was to determine the ameliorative effects of a crude extract of Vaccaria segetalis (Neck.) Garcke (Caryophyllaceae) (VSE) on osteopenia in ovariectomized (OVX) rats over 12 weeks. Rats were divided into the sham and OVX groups. The OVX rats were allowed to lose bone for 6 weeks. At 6 weeks post-OVX, the OVX rats were divided into four groups treated with water, 17β-estradiol (30 μg/kg, daily subcutaneous injection), or VSE (0.5 or 1.0 g/kg, daily, orally) for 6 weeks. In OVX rats, the increases of serum total cholesterol were significantly decreased by VSE or 17β-estradiol treatment. There were decreases in bone density and calcium content, including the left femur and the fourth lumbar vertebra, when compared with the sham control rats. Treatment with 17β-estradiol or VSE ameliorated these changes induced by OVX. In addition, ovariectomy increased urinary deoxypyridinoline (DPD) amounts (P < 0.001). The increases were suppressed by 17β-estradiol and 0.5 or 1.0 g/kg VSE (P < 0.01, P < 0.05, P < 0.01, respectively). Our results demonstrated that VSE ameliorates ovariectomy-induced osteopenia by inhibition of bone resorption.
Literatur
1.
Zurück zum Zitat Jiangsu ME (1986) New Medical Academy, Zhong-yao-da-ci-dian. Shanghai Science and Technology, Shanghai, p 311 Jiangsu ME (1986) New Medical Academy, Zhong-yao-da-ci-dian. Shanghai Science and Technology, Shanghai, p 311
2.
Zurück zum Zitat Itokawa H, Yun YS, Morita H, Takeya K, Yamada K (1995) Estrogen-like activity of cyclic peptides from Vaccaria segetalis extracts. Planta Med 61:561–562PubMedCrossRef Itokawa H, Yun YS, Morita H, Takeya K, Yamada K (1995) Estrogen-like activity of cyclic peptides from Vaccaria segetalis extracts. Planta Med 61:561–562PubMedCrossRef
3.
Zurück zum Zitat Morita H, Yun YS, Takeya K, Itokawa H, Shirota O (1995) A cyclic heptapeptide from Vaccaria segetalis. Phytochemistry 42(2):439–441CrossRef Morita H, Yun YS, Takeya K, Itokawa H, Shirota O (1995) A cyclic heptapeptide from Vaccaria segetalis. Phytochemistry 42(2):439–441CrossRef
4.
Zurück zum Zitat Yun YS, Morita H, Takeya K, Itokawa H (1997) Cyclic peptides from higher plants. 34. Segetalins G and H, structures and estrogen-like activity of cyclic pentapeptides from Vaccaria segetalis. J Nat Prod 60:216–218PubMedCrossRef Yun YS, Morita H, Takeya K, Itokawa H (1997) Cyclic peptides from higher plants. 34. Segetalins G and H, structures and estrogen-like activity of cyclic pentapeptides from Vaccaria segetalis. J Nat Prod 60:216–218PubMedCrossRef
5.
Zurück zum Zitat Koike K, Jia Z, Nikaido T (1998) Triterpenoid saponins from Vaccaria segetalis. Phytochemistry 47(7):1343–1349PubMedCrossRef Koike K, Jia Z, Nikaido T (1998) Triterpenoid saponins from Vaccaria segetalis. Phytochemistry 47(7):1343–1349PubMedCrossRef
6.
Zurück zum Zitat Jia Z, Koike K, Kudo M, Li H, Nikaido T (1998) Triterpenoid saponins and sapogenins from Vaccaria segetalis. Phytochemistry 48(3):529–536PubMedCrossRef Jia Z, Koike K, Kudo M, Li H, Nikaido T (1998) Triterpenoid saponins and sapogenins from Vaccaria segetalis. Phytochemistry 48(3):529–536PubMedCrossRef
7.
Zurück zum Zitat Sang S, Lao A, Wang H, Chen Z, Uzawa J, Fujimoyo Y (1998) A phenylpropanoid glycoside from Vaccaria segetalis. Phytochemistry 48(3):567–571CrossRef Sang S, Lao A, Wang H, Chen Z, Uzawa J, Fujimoyo Y (1998) A phenylpropanoid glycoside from Vaccaria segetalis. Phytochemistry 48(3):567–571CrossRef
8.
Zurück zum Zitat Kalu DK (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175–192PubMedCrossRef Kalu DK (1991) The ovariectomized rat model of postmenopausal bone loss. Bone Miner 15:175–192PubMedCrossRef
9.
Zurück zum Zitat Prestwood KM, Kenny AM, Unson C, Kulldorff M (2000) The effect of low dose micronized 17β-estradiol on bone turnover, sex hormone levels, and side effects in order women: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 85:4462–4469PubMedCrossRef Prestwood KM, Kenny AM, Unson C, Kulldorff M (2000) The effect of low dose micronized 17β-estradiol on bone turnover, sex hormone levels, and side effects in order women: a randomized, double-blind, placebo-controlled study. J Clin Endocrinol Metab 85:4462–4469PubMedCrossRef
10.
Zurück zum Zitat Delmas PD, Pornel B, Felsenberg D (2001) Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women. Am J Obstet Gynecol 184:32–40PubMedCrossRef Delmas PD, Pornel B, Felsenberg D (2001) Three-year follow-up of the use of transdermal 17β-estradiol matrix patches for the prevention of bone loss in early postmenopausal women. Am J Obstet Gynecol 184:32–40PubMedCrossRef
11.
Zurück zum Zitat Ettinger B, Ensrud KE, Wallace R (2004) Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 104:443–451PubMed Ettinger B, Ensrud KE, Wallace R (2004) Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial. Obstet Gynecol 104:443–451PubMed
12.
Zurück zum Zitat Kalu DK, Liu CC, Salerno E (1991) Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14:175–187PubMedCrossRef Kalu DK, Liu CC, Salerno E (1991) Skeletal response of ovariectomized rats to low and high doses of 17β-estradiol. Bone Miner 14:175–187PubMedCrossRef
13.
Zurück zum Zitat Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidesy-Frink KL, Ma YF, Jee WSS, Thompson DD (1997) Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 20:31–39PubMedCrossRef Ke HZ, Chen HK, Simmons HA, Qi H, Crawford DT, Pirie CM, Chidesy-Frink KL, Ma YF, Jee WSS, Thompson DD (1997) Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone 20:31–39PubMedCrossRef
14.
Zurück zum Zitat Miller SC, Bowman BM, Miller MA (1991) Calcium absorption and osseous organ-, tissue-, and envelope-specific changes following ovariectomy in rats. Bone 12:439–446PubMedCrossRef Miller SC, Bowman BM, Miller MA (1991) Calcium absorption and osseous organ-, tissue-, and envelope-specific changes following ovariectomy in rats. Bone 12:439–446PubMedCrossRef
15.
Zurück zum Zitat Jiang Y, Zhao J, Genant HK (1998) Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats. J Bone Miner Res 12:820–831CrossRef Jiang Y, Zhao J, Genant HK (1998) Long-term changes in bone mineral and biomechanical properties of vertebrae and femur in aging, dietary calcium restricted, and/or estrogen-deprived/-replaced rats. J Bone Miner Res 12:820–831CrossRef
16.
Zurück zum Zitat Li X, Takahashi M, Kushida K (1998) The preventive and interventional effects of raloxifene analog (LY 117018 HCL) on osteopenia in ovariectomized rats. J Bone Miner Res 13:1005–1010PubMedCrossRef Li X, Takahashi M, Kushida K (1998) The preventive and interventional effects of raloxifene analog (LY 117018 HCL) on osteopenia in ovariectomized rats. J Bone Miner Res 13:1005–1010PubMedCrossRef
17.
Zurück zum Zitat Marie PJ, Hott M, Modrowski D (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–615PubMed Marie PJ, Hott M, Modrowski D (1993) An uncoupling agent containing strontium prevents bone loss by depressing bone resorption and maintaining bone formation in estrogen-deficient rats. J Bone Miner Res 8:607–615PubMed
18.
Zurück zum Zitat Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Linssay R (1993) Urinary hydroxypyridium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 8:881–889PubMedCrossRef Seibel MJ, Cosman F, Shen V, Gordon S, Dempster DW, Ratcliffe A, Linssay R (1993) Urinary hydroxypyridium crosslinks of collagen as markers of bone resorption and estrogen efficacy in postmenopausal osteoporosis. J Bone Miner Res 8:881–889PubMedCrossRef
19.
Zurück zum Zitat Svanberg M, Knuuttila M (1994) Dietary xylitol prevents ovariectomy induced changed of bone inorganic fraction in rats. Bone Miner 26:81–88PubMedCrossRef Svanberg M, Knuuttila M (1994) Dietary xylitol prevents ovariectomy induced changed of bone inorganic fraction in rats. Bone Miner 26:81–88PubMedCrossRef
20.
Zurück zum Zitat Frolik CA, Bryant HU, Black EC (1996) Time-dependent changes in biochemical bone makers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifene, estrogen, and alendronate. Bone 18:621–627PubMedCrossRef Frolik CA, Bryant HU, Black EC (1996) Time-dependent changes in biochemical bone makers and serum cholesterol in ovariectomized rats: effects of raloxifene HCl, tamoxifene, estrogen, and alendronate. Bone 18:621–627PubMedCrossRef
21.
Zurück zum Zitat Luo S, Sourla A, Labrie C (1998) Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice. Endocrinology 139:2645–2656PubMedCrossRef Luo S, Sourla A, Labrie C (1998) Effect of twenty-four-week treatment with the antiestrogen EM-800 on estrogen-sensitive parameters in intact and ovariectomized mice. Endocrinology 139:2645–2656PubMedCrossRef
22.
Zurück zum Zitat Black LJ, Sato M, Rowley ER (1994) Raloxifene (LY 139481 HCL) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63–69PubMedCrossRef Black LJ, Sato M, Rowley ER (1994) Raloxifene (LY 139481 HCL) prevents bone loss and reduces serum cholesterol without causing uterine hypertrophy in ovariectomized rats. J Clin Invest 93:63–69PubMedCrossRef
23.
Zurück zum Zitat VanNesselrooij JH, Szeverenyi NM, Ruocco MJ (1989) Magnetic resonance imaging of estrogen-induced pituitary hypertrophy in rats. Magn Reson Med 11:161–171CrossRef VanNesselrooij JH, Szeverenyi NM, Ruocco MJ (1989) Magnetic resonance imaging of estrogen-induced pituitary hypertrophy in rats. Magn Reson Med 11:161–171CrossRef
Metadaten
Titel
Ameliorative effects of Vaccaria segetalis extract on osteopenia in ovariectomized rats
verfasst von
Chun-Ching Shih
Cheng-Hsiu Lin
Wei-Li Lin
Publikationsdatum
01.10.2009
Verlag
Springer Japan
Erschienen in
Journal of Natural Medicines / Ausgabe 4/2009
Print ISSN: 1340-3443
Elektronische ISSN: 1861-0293
DOI
https://doi.org/10.1007/s11418-009-0341-9

Weitere Artikel der Ausgabe 4/2009

Journal of Natural Medicines 4/2009 Zur Ausgabe